Feed PTIXW
PT

Protagenic Therapeutics, Inc. PTIXW NASDAQ · Healthcare · United States

$0.02 +0.00% +$0.00

Summary

73 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 35,481 USD is left as net profit.
  • It earns 149 USD a year on every 100 USD of invested capital.
  • It has no debt and holds $362.5K in cash.

What to watch

  • It passes only 2 of the 9 points of the Piotroski financial health test.
  • For every 100 USD of bills due within a year it has 29 USD of short-term assets.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Valuation in detail

Is it growing?

Revenue (USD)

There is not enough revenue history yet to say how fast it grows.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

This revenue breakdown is on the way.

By region

This revenue breakdown is on the way.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy